Brief: SynAct Pharma Files Patent Application

SynAct Pharma AB

25/05/2020 07:17

May 25 (Reuters) - SynAct Pharma AB  SYNACT.TE :
    * SYNACT PHARMA FILES PATENT APPLICATION FOR COMBINATION OF
AP1189
AND METHOTREXATE FOR TREATMENT OF RA AND OTHER ARTHRITIC
DISEASES
    * PURPOSE OF PATENT APPLICATION IS TO ADD AN ADDITIONAL
LEVEL OF
IP PROTECTION TO OUR AP1189 COMPOUND

Source text for Eikon:  ID:nWkr1jX9Ck 
Further company coverage:  SYNACT.TE 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 587785110;))